Literature DB >> 7874107

A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1.

S L Neuhausen1, J Swensen, Y Miki, Q Liu, S Tavtigian, D Shattuck-Eidens, A Kamb, M R Hobbs, J Gingrich, H Shizuya.   

Abstract

BRCA1, a breast and ovarian cancer susceptibility locus, has been isolated and maps to 17q21. A physical map of the BRCA1 region which extended from the proximal boundary at D17S776 to the distal boundary at D17S78 was constructed and consists of 51 sequence tagged sites (STSs) from P1 and YAC ends, nine new short-tandem repeat (STR) polymorphic markers, and eight identified genes. The contig, which spans the estimated 2.3 Mb region, contains 29 P1s, 11 YACs, two BACs, and one cosmid. Based on key recombinants in two linked families, BRCA1 was further localized to a region bounded by D17S1321 on the proximal side and D17S1325 on the distal side. Within this estimated 600 kb region, the contig was composed completely of P1s and BACs ordered by STS-content mapping and confirmed by DNA restriction fragment fingerprinting.

Entities:  

Mesh:

Year:  1994        PMID: 7874107     DOI: 10.1093/hmg/3.11.1919

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

Authors:  Danièle Muller; Catherine Bonaiti-Pellié; Joseph Abecassis; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

3.  Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

Authors:  F Durocher; P Tonin; D Shattuck-Eidens; M Skolnick; S A Narod; J Simard
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

4.  Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.

Authors:  D B Berman; J Wagner-Costalas; D C Schultz; H T Lynch; M Daly; A K Godwin
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

5.  Analysis of BRCA1 involvement in breast cancer in Indian women.

Authors:  P H Pestonjamasp; I Mittra
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

6.  Concerted evolution of the tandemly repeated genes encoding human U2 snRNA (the RNU2 locus) involves rapid intrachromosomal homogenization and rare interchromosomal gene conversion.

Authors:  D Liao; T Pavelitz; J R Kidd; K K Kidd; A M Weiner
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

7.  Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1.

Authors:  T Hattier; R Bell; D Shaffer; S Stone; R S Phelps; S V Tavtigian; M H Skolnick; D Shattuck-Eidens; A Kamb
Journal:  Mamm Genome       Date:  1995-12       Impact factor: 2.957

8.  Molecular haplotyping of genetic markers 10 kb apart by allele-specific long-range PCR.

Authors:  S Michalatos-Beloin; S A Tishkoff; K L Bentley; K K Kidd; G Ruano
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

9.  Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis.

Authors:  K Avela; M Lipsanen-Nyman; J Perheentupa; C Wallgren-Pettersson; S Marchand; S Fauré; P Sistonen; A de la Chapelle; A E Lehesjoki
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

10.  The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.

Authors:  H Aberle; C Bierkamp; D Torchard; O Serova; T Wagner; E Natt; J Wirsching; C Heidkämper; M Montagna; H T Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.